THC as reported
Tenet Healthcare Corporation reported $21.8B of revenue over the trailing twelve months, +5.4% on the year before. 10 reported series are charted on this page, each one as filed.
$21.8B
Revenue, trailing twelve months · to Q2 2026 · +5.4% against the twelve months before
- Net Income
- $3.17B
Net Income · +32% year on year · trailing twelve months to Q2 2026
- Free Cash Flow
- $3.02B
Free Cash Flow · +95% year on year · trailing twelve months to Q2 2026
- Op Margin
- 21%
Op Margin · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $21.8B | +5.4% | Q2 2026 |
| Net Income | $3.17B | +32% | Q2 2026 |
| EPS | $25.92 | +65% | Q2 2026 |
| Op Margin | 21% | n/a | Q2 2026 |
| Net Margin | 15% | n/a | Q2 2026 |
| ROE | 59% | n/a | Q2 2026 |
| ROA | 8.7% | n/a | Q2 2026 |
| ROIC | 20% | n/a | Q2 2026 |
| Free Cash Flow | $3.02B | +95% | Q2 2026 |
| P/E | 10.6 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Tenet Healthcare Corporation (THC) - Revenue & ProfitRevenue & ProfitTenet Healthcare Corporation (THC)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Care Facilities
Ranks #1 of 28 by Smart Score